Lipitor Lawsuit Alleges Pfizer Misled Public, Promoted Medicare Fraud

Injury and Accident Attorneys Serving St. Louis, Nearby Missouri, Fairview Heights, and Nearby Illinois

Share:

A Lipitor whistleblower lawsuit is alleging that Pfizer intentionally manipulated the public’s knowledge of Lipitor to artificially increase its profits.
A Lipitor whistleblower lawsuit is alleging that
Pfizer intentionally manipulated the public’s
knowledge of Lipitor to artificially increase its
profits.

A Lipitor whistleblower lawsuit filed against Pfizer by Health Support Awareness is alleging that Pfizer intentionally manipulated the public’s knowledge of Lipitor in order to artificially increase the need for the drug and, in turn, attempt to boost the company’s profits (Case 1:13-cv-11917-NMG).

According to the complaint associated with this case (which may also be referred to as a qui tam lawsuit), Pfizer:

  • Paid off Ranbaxy, a company that makes generic medications, to hold off on its production of a generic version of Lipitor (which is prescribed to manage high cholesterol levels)
  • Tried to influence medical professionals regarding “safe” levels of cholesterol by specifically attempting to get these professionals to lower their recommended “healthy” cholesterol levels, which would, as a result, increase the number of patients that would supposedly need to take Lipitor
  • Cost Medicare billions of dollars in possibly unnecessary Lipitor claims due to its unethical practices – In fact, according to court documents, in 2010 alone, Medicare paid out more than $6.5 billion in Lipitor claims. Additionally, between 2007 and 2010, more than 40 percent of Medicare patients were taking Lipitor to manage their cholesterol levels.

While this lawsuit was originally filed in August 2013, specifics regarding the allegations mounted against Pfizer were only recently made public due to the strict confidentiality restrictions imposed on whistleblower lawsuits. Specifically, plaintiffs in such qui tam lawsuits are required not to publically disclose the allegations in their cases until the Department of Justice (DoJ) has the opportunity to decide whether it will pursue its own criminal case against the defendant. For this Lipitor whistleblower lawsuit, the DoJ has passed on opening a separate criminal case against Pfizer.

St. Louis Dangerous Drug Lawyers

If you have developed serious health complications after taking Lipitor or any potentially dangerous drug, contact the St. Louis dangerous drug lawyers at Brown & Brown Attorneys at Law. We have a long-standing commitment to serving our clients, and we are experienced at aggressively defending our clients’ rights in any legal setting. Our goal is to preserve and promote the rights and welfare of individuals and families who have suffered injuries and losses and/or who need help navigating through the complexities of the court system.

Since 1993, our lawyers have been successfully representing our clients in various areas of personal injury litigation, including dangerous drug and product liability lawsuits. Our unwavering dedication to the pursuit of justice in every case we handle means that we will work relentlessly to help our clients achieve the best possible outcomes to their cases. One of our primary goals is to help accident victims secure the maximum possible compensation for their injuries and losses so they can focus on their recovery and moving on with their lives.

For a free initial consult, email us using the form at the right-hand side of the screen and/or to call us at 573-333-3333 for our Missouri office or at 618-888-8888 for our Illinois office.